VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
60 hedge funds and large institutions have $111M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 62 → 60 (-2)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
18% less capital invested
Capital invested by funds: $136M → $111M (-$24.5M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$619K |
| 2 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$445K |
| 3 |
State Street
Boston,
Massachusetts
|
+$313K |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$243K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$134K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$532K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$474K |
| 3 |
Renaissance Technologies
New York
|
-$391K |
| 4 |
JP Morgan Chase
New York
|
-$235K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$124K |
VBIV Hedge Fund Activity: Q1 2018 in Review
60 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2018, worth a combined $111M — down 18% from $136M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VBIV and 4 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 14 added.
The largest buyer was DZ Bank, opening a new position worth an estimated $619K. The largest seller was Sphera Funds Management, cutting an estimated $532K.
- 60 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2018, down from 62 in Q4 2017.
- Funds reported $111M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2018, down 18% quarter-over-quarter.
- 4 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2018 and 6 closed out, a net change of -2 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2018 was DZ Bank, an estimated $619K added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2018 was Sphera Funds Management, an estimated $532K sold.
Based on aggregated 13F filings for Q1 2018.